IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0240713.html
   My bibliography  Save this article

A follow-up study on the effects of an educational intervention against pharmaceutical promotion

Author

Listed:
  • M Murat Civaner

Abstract

Background: The promotion strategies of pharmaceutical companies create many problems including irrational prescribing, diminished trust in the patient-physician relationship and unnecessary increases in pharmaceutical costs. Educating prescribers is known to be one of the few potentially effective measures to counteract those impacts. However such educational programs are limited in the literature, and their effectiveness against the effects of hidden curriculum in the long term is unknown. This study aims to evaluate the effectiveness of an education program both in the short term and the long term after the students have been exposed to informal and hidden curriculum and various pharmaceutical promotion methods. Methods: A longitudinal and controlled study was carried out in a school of medicine in Turkey where there are no restrictive policies for pharmaceutical promotion. A survey was applied to 123 students who attended the class throughout the terms of 2011–12, 2012–13, and 2013–14, evaluating the pre-educational status of students’ opinions of promotion and any post-educational changes. A follow-up study four years later asked those three cohorts to fill out the same survey to see the possible effects of the clinical environment and various promotion methods. Also, the opinions of all 518 sixth-year students who had not taken the class in those three terms were compared to the educated students. Results: The program was significantly effective in the short term in changing students’ opinions and attitudes positively towards recognizing companies’ discourse and promotion strategies. But in the long term, the education lost its ability to convince students of the importance of not getting financial support for scientific activities from pharmaceutical companies (p:0.006) and carrying out research (p

Suggested Citation

  • M Murat Civaner, 2020. "A follow-up study on the effects of an educational intervention against pharmaceutical promotion," PLOS ONE, Public Library of Science, vol. 15(10), pages 1-16, October.
  • Handle: RePEc:plo:pone00:0240713
    DOI: 10.1371/journal.pone.0240713
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240713
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0240713&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0240713?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Kirsten E Austad & Jerry Avorn & Aaron S Kesselheim, 2011. "Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review," Working Papers id:4237, eSocialSciences.
    2. Civaner, Murat, 2012. "Sale strategies of pharmaceutical companies in a “pharmerging” country: The problems will not improve if the gaps remain," Health Policy, Elsevier, vol. 106(3), pages 225-232.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.
    2. Paul Scheffer & Christian Guy-Coichard & David Outh-Gauer & Zoéline Calet-Froissart & Mathilde Boursier & Barbara Mintzes & Jean-Sébastien Borde, 2017. "Conflict of Interest Policies at French Medical Schools: Starting from the Bottom," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-13, January.
    3. Holloway, Kelly, 2014. "Uneasy subjects: Medical students' conflicts over the pharmaceutical industry," Social Science & Medicine, Elsevier, vol. 114(C), pages 113-120.
    4. Jesse R. Catlin & Cornelia (Connie) Pechmann, 2016. "An Investigation of Consumer and Doctor Regulatory Beliefs and Regulatory Knowledge about Pharmaceutical Drug Promotions," Journal of the Association for Consumer Research, University of Chicago Press, vol. 1(3), pages 392-410.
    5. Christian Guy-Coichard & Gabriel Perraud & Anne Chailleu & Véronique Gaillac & Paul Scheffer & Barbara Mintzes, 2019. "Inadequate conflict of interest policies at most French teaching hospitals: A survey and website analysis," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-15, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0240713. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.